<DOC>
	<DOC>NCT00830791</DOC>
	<brief_summary>This study will assess the pharmacokinetics of MK-0941 in participants with varying degrees of renal insufficiency.</brief_summary>
	<brief_title>A Single Dose Study to Investigate the Pharmacokinetics of MK-0941 in Participants With Renal Insufficiency (MK-0941-015-02)</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Male or nonpregnant female age 18 to 75 years Female of childbearing potential on appropriate method of contraception Body mass index (BMI) less than or equal to 40 kg/m2 Participant is in good health Participant diagnosed with Type 2 Diabetes Participant agrees to follow smoking restrictions Willing to follow the study diet restrictions Mental or legal incapacitation Participant has had kidney removed History of Type 1 diabetes History of stroke, chronic seizures or major neurological disorder History of neoplastic disease Nursing mother Consumes greater than 4 glasses of alcoholic beverages per day Consumes greater than 6 servings of caffeinated beverages per day Participant has had surgery or donated 1 unit of blood within 1 month of screening Participant has history of recent eye infection within 2 weeks of study drug administration Clinically diagnosed with glaucoma or blindness Has trauma to one or both eyes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>